Haileraguel Hailemichael: Antiphospholipid Syndrome Testing – When Blood Clots Point to an Autoimmune Cause
Haileraguel Hailemichael, Laboratory Project Manager at Micro pharma PLC, shared a post on LinkedIn:
“Antiphospholipid Syndrome (APS) Testing: When Blood Clots Point to an Autoimmune Cause
A young patient develops a deep vein thrombosis (DVT) with no obvious risk factors.
Or a woman experiences recurrent miscarriages despite otherwise normal health.
Could an autoimmune disorder be the underlying cause?
This is where Antiphospholipid Syndrome (APS) testing becomes essential.
What is Antiphospholipid Syndrome (APS)?
APS is an autoimmune disorder in which the body produces antibodies against phospholipid-binding proteins, increasing the risk of:
- Venous thrombosis (e.g., DVT, pulmonary embolism)
- Arterial thrombosis (e.g., stroke)
- Recurrent pregnancy loss
- Pregnancy complications (such as preeclampsia or fetal growth restriction)
APS may occur on its own (primary APS) or in association with autoimmune diseases such as Systemic Lupus Erythematosus (SLE).
The Three Main Laboratory Tests
1.Lupus Anticoagulant (LA)
Despite its name, Lupus Anticoagulant is associated with an increased risk of clotting, not bleeding.
It is detected using clot-based coagulation assays.
2.Anticardiolipin Antibodies (aCL)
Measured as:
- IgG
- IgM
Persistent moderate-to-high levels support the diagnosis of APS.
3.Anti-β2 Glycoprotein I (Anti-β2GPI)
Measured as:
- IgG
- IgM
Highly specific for APS and an important part of the diagnostic criteria.
Real Clinical Scenario
A 32-year-old woman presents with:
- Three consecutive first-trimester miscarriages
- No structural uterine abnormalities
- No hormonal cause identified
Laboratory results:
Lupus Anticoagulant: Positive
Anticardiolipin IgG: Positive
These findings strongly support Antiphospholipid Syndrome (APS) when confirmed with repeat testing.
Important Clinical Pearls
- APS testing should not be performed during an acute thrombotic event or while on certain anticoagulants without considering their effect on test interpretation.
- A diagnosis of APS requires persistent positivity—the same antibody should be positive on two occasions at least 12 weeks apart, together with an appropriate clinical event.
- A single positive antibody result does not confirm APS.
- Patients who are ‘triple positive’ (LA and aCL and Anti-β2GPI) are generally at the highest risk for thrombosis and pregnancy complications.
Key Clinical Message
- Think about APS testing in patients with:
- Unexplained venous or arterial thrombosis at a young age
- Recurrent pregnancy loss
- Stroke without traditional cardiovascular risk factors
- Suspected or confirmed SLE with thrombotic complications
- The right antibody test can explain what routine coagulation tests cannot—and may prevent future thrombotic events and pregnancy complications.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026